RGC Regencell Bioscience Holdings Ltd
Fundamentals / CIK 0001829667 / USDRegencell Bioscience Holdings Ltd reported $14.73M in total assets and a net loss of $11.70M through June 30, 2026 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RGC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2026-- Jun 30, 2026
-
Operating Income FY 2026-$11.72M Operating profit
-
Net Income FY 2026-$11.70M GAAP bottom line
-
Diluted EPS FY 2026-$2.37 Split-adjusted
-
Free Cash Flow FY 2026-- Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026$14.19M Total debt: $296K
Annual revenue and net income
8 fiscal years (2019 to 2026), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $1.30M | $948K | $1.07M | $1.58M | $2.51M | $438K | $386K | $228K |
| Selling, General & Admin | $10.42M | $2.82M | $3.67M | $4.69M | $5.11M | $943K | $426K | $163K |
| Total Operating Expenses | $11.72M | $3.77M | $4.74M | $6.27M | $7.62M | $1.38M | $812K | $391K |
| Operating Income | -$11.72M | -$3.77M | -$4.74M | -$6.27M | -$7.62M | -$1.38M | -$812K | -$391K |
| EBITDA | -$11.64M | -$3.69M | -$4.43M | -$5.98M | -$7.01M | -$1.35M | -$803K | -- |
| Interest Income | $23K | $186K | $248K | $85K | $11K | -- | -- | -- |
| Income Before Tax | -$11.70M | -$3.58M | -$4.36M | -$6.06M | -$7.59M | -$1.35M | -$812K | -$391K |
| Net Income | -$11.70M | -$3.58M | -$4.30M | -$5.87M | -$7.45M | -$1.35M | -$812K | -$391K |
| Basic EPS | -$2.37 | -$0.72 | -$0.87 | -$1.19 | -$0.58 | $0.13 | $0.08 | -- |
| Diluted EPS | -$2.37 | -$0.72 | -$0.87 | -$1.19 | -$0.58 | -$0.13 | -$0.08 | -- |
| Basic Shares Outstanding | 494.6M | 494.5M | 494.5M | 494.5M | 12.8M | 10.0M | 10.0M | 0 |
| Diluted Shares Outstanding | 494.6M | 494.5M | 494.5M | 494.5M | 12.8M | 10.0M | 10.0M | 10.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $14.19M | $2.42M | $2.96M | $1.56M | $6.42M | $59K | $387K |
| Short-Term Investments | -- | $2.48M | $5.00M | $10.00M | $10.00M | -- | -- |
| Cash & Short-Term Investments | $14.19M | $4.90M | $7.96M | $11.56M | $16.42M | $59K | $387K |
| Total Current Assets | $14.22M | $4.90M | $8.11M | $11.62M | $16.44M | $67K | $387K |
| Property, Plant & Equipment, Net | $135K | $215K | $142K | $441K | $713K | $82K | $108K |
| Total Non-Current Assets | $506K | $853K | $324K | $1.00M | $1.57M | $273K | $127K |
| Total Assets | $14.73M | $5.76M | $8.44M | $12.62M | $18.02M | $340K | $514K |
| Total Current Liabilities | $1.32M | $664K | $194K | $607K | $578K | $4.34M | $3.16M |
| Total Non-Current Liabilities | $59K | $232K | $26K | $25K | $360K | $0 | $0 |
| Total Liabilities | $1.38M | $895K | $220K | $632K | $938K | $4.34M | $3.16M |
| Total Debt (incl. Leases) | $296K | $544K | $86K | $464K | $771K | -- | -- |
| Common Stock | $5.0K | $4.9K | $130 | $130 | $130 | $100 | $100 |
| Retained Earnings | -$36.90M | -$25.20M | -$21.62M | -$17.32M | -$11.44M | -$4.00M | -$2.65M |
| Accumulated Other Comp. Income | -$45K | -$65K | -$46K | -$87K | -- | -- | -- |
| Total Stockholders' Equity | $13.35M | $4.86M | $8.22M | $12.03M | $17.07M | -$4.00M | -$2.65M |
| Total Equity | $13.35M | $4.86M | $8.22M | $11.99M | $17.08M | -$4.00M | -$2.65M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $14.19M | $2.42M | $2.96M | $1.56M | $6.42M | $59K | $387K |
| Short-Term Investments | -- | $2.48M | $5.00M | $10.00M | $10.00M | -- | -- |
| Cash & Short-Term Investments | $14.19M | $4.90M | $7.96M | $11.56M | $16.42M | $59K | $387K |
| Total Current Assets | $14.22M | $4.90M | $8.11M | $11.62M | $16.44M | $67K | $387K |
| Property, Plant & Equipment, Net | $135K | $215K | $142K | $441K | $713K | $82K | $108K |
| Total Non-Current Assets | $506K | $853K | $324K | $1.00M | $1.57M | $273K | $127K |
| Total Assets | $14.73M | $5.76M | $8.44M | $12.62M | $18.02M | $340K | $514K |
| Total Current Liabilities | $1.32M | $664K | $194K | $607K | $578K | $4.34M | $3.16M |
| Total Non-Current Liabilities | $59K | $232K | $26K | $25K | $360K | $0 | $0 |
| Total Liabilities | $1.38M | $895K | $220K | $632K | $938K | $4.34M | $3.16M |
| Total Debt (incl. Leases) | $296K | $544K | $86K | $464K | $771K | -- | -- |
| Common Stock | $5.0K | $4.9K | $130 | $130 | $130 | $100 | $100 |
| Retained Earnings | -$36.90M | -$25.20M | -$21.62M | -$17.32M | -$11.44M | -$4.00M | -$2.65M |
| Accumulated Other Comp. Income | -$45K | -$65K | -$46K | -$87K | -- | -- | -- |
| Total Stockholders' Equity | $13.35M | $4.86M | $8.22M | $12.03M | $17.07M | -$4.00M | -$2.65M |
| Total Equity | $13.35M | $4.86M | $8.22M | $11.99M | $17.08M | -$4.00M | -$2.65M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$11.70M | -$3.58M | -$4.36M | -$6.06M | -$7.59M | -$1.35M | -$812K | -$391K |
| Depreciation & Amortization | $81K | $78K | $306K | $293K | $604K | $26K | $9.5K | -- |
| Stock-Based Compensation | $3.23M | $245K | $449K | $923K | $2.76M | $923K | -- | -- |
| Operating Cash Flow | -$7.70M | -$3.11M | -$4.00M | -$4.96M | -$5.27M | -$767K | -$727K | -$391K |
| Capital Expenditure | -- | -$153K | -$5.4K | -$27K | -$781K | -- | -$118K | -- |
| Free Cash Flow | -- | -$3.27M | -$4.01M | -$4.99M | -$6.05M | -- | -$844K | -- |
| Investing Cash Flow | $2.50M | $2.69M | $5.24M | $59K | -$10.78M | -- | -$118K | -- |
| Common Stock Issued | $18.62M | -- | -- | -- | -- | -- | -- | -- |
| Financing Cash Flow | $16.95M | -- | $102K | $135K | $22.41M | $440K | $988K | $481K |
| Net Change in Cash | $11.77M | -$542K | $1.40M | -$4.85M | $6.36M | -$328K | $144K | $90K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -87.7% | -73.7% | -52.3% | -48.8% | -43.6% | -- | -- | -- |
| Return on Assets (ROA) | -79.4% | -62.3% | -51.0% | -46.5% | -41.3% | -395.9% | -158.0% | -- |
| Current Ratio | 10.77x | 7.39x | 41.92x | 19.15x | 28.46x | 0.02x | 0.12x | -- |
| Quick Ratio | 10.75x | 7.38x | 41.13x | 19.06x | 28.41x | 0.01x | 0.12x | -- |
| Debt to Equity | 0.02x | 0.11x | 0.01x | 0.04x | 0.05x | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -546.2% | +62.5% | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.